Open AccessJournal Article
The legal and clinical implications of crushing tablet medication.
Reads0
Chats0
TLDR
There may be times when tablets will need to be crushed in order to deliver essential drug therapy; this should only be done as a last resort.Abstract:
It has recently been estimated that 75 per cent of all older patients will fail to comply with their medication regimes at some point during their hospital stay (Wright, 2002). Crushing tablets or opening capsules in order to assist a patient with swallowing difficulties appears to be a widespread activity. There may be times when tablets will need to be crushed in order to deliver essential drug therapy; this should only be done as a last resort. Crushing tablets is a practice that has the potential to endanger patient safety and contravene legal and professional requirements.read more
Citations
More filters
Patent
Abuse-proofed dosage forms
TL;DR: In this article, a form of administration which is secured against misuse and which is thermoformed without extrusion, comprising at least one synthetic or natural polymer having a resistance to breaking of at least 500 N in addition to one or several active ingredients with a misuse potential and, optionally physiologically compatible auxiliary substances.
Patent
Pharmaceutical dosage form
Eugeen Marie Jozef Jans,Filip Kiekens,Jody Firmin Marceline Voorspoels,Anne Faure,Arkenau-Maric Elisabeth,Barnscheid Lutz,Bartholomaus Johannes,Marc Frevel,Eric Galia,Iris Ziegler +9 more
TL;DR: In this article, a pharmaceutical dosage form with controlled release of a pharmacologically active compound (A) contained therein, the dosage form very preferably being tamper-resistant and most preferably having a breaking strength B1 of at least 500 N in direction of extension E1 and having a break strength B2 of less than 500 n in direction E2.
Journal Article
Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
Beverley Glass,Alison Haywood +1 more
TL;DR: It may be concluded that when considering the safety and efficacy of liquid dosage forms prepared extemporaneously, it is thus important to consider not only the stability of the drug substance but the entire formulation.
Patent
Process for the production of an abuse-proofed dosage form
TL;DR: In this paper, a process for the production of abuse-proofed, thermoformed dosage forms containing, apart from one or more active ingredients with potential for abuse and optionally physiologically acceptable auxiliary substances, at least one synthetic or natural polymer with a breaking strength of at least 500 N.
Patent
Crush resistant delayed-release dosage forms
TL;DR: In this paper, the authors defined a dosage form comprising a physiologically effective amount of a physically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or more physiologically acceptable auxiliary substances (B) and optionally a synthetic or natural wax (D), where the dosage form exhibits a resistance to crushing of at least 400 N and wherein under physiological conditions the release of the physiologically active substance from the dosage forms is at least partially delayed.